Search tips
Search criteria 


Logo of jrsocmedLink to Publisher's site
J R Soc Med. 1999 November; 92(11): 566–570.
PMCID: PMC1297431

Herpes simplex virus vectors for gene therapy in Parkinson's disease and other diseases of the nervous system.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (750K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Anderson WF. Human gene therapy. Nature. 1998 Apr 30;392(6679 Suppl):25–30. [PubMed]
  • Haase G, Kennel P, Pettmann B, Vigne E, Akli S, Revah F, Schmalbruch H, Kahn A. Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat Med. 1997 Apr;3(4):429–436. [PubMed]
  • Latchman DS. Heat shock proteins: protective effect and potential therapeutic use (review). Int J Mol Med. 1998 Oct;2(4):375–381. [PubMed]
  • Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD, et al. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science. 1990 Feb 2;247(4942):574–577. [PubMed]
  • Bencsics C, Wachtel SR, Milstien S, Hatakeyama K, Becker JB, Kang UJ. Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. J Neurosci. 1996 Jul 15;16(14):4449–4456. [PubMed]
  • Lapchak PA, Miller PJ, Jiao S, Araujo DM, Hilt D, Collins F. Biology of glial cell line-derived neurotrophic factor (GDNF): implications for the use of GDNF to treat Parkinson's disease. Neurodegeneration. 1996 Sep;5(3):197–205. [PubMed]
  • Lapchak PA. Therapeutic potentials for glial cell line-derived neurotrophic factor (GDNF) based upon pharmacological activities in the CNS. Rev Neurosci. 1996 Jul-Sep;7(3):165–176. [PubMed]
  • Fisher LJ, Jinnah HA, Kale LC, Higgins GA, Gage FH. Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron. 1991 Mar;6(3):371–380. [PubMed]
  • Horellou P, Vigne E, Castel MN, Barnéoud P, Colin P, Perricaudet M, Delaère P, Mallet J. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport. 1994 Dec 30;6(1):49–53. [PubMed]
  • Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O'Malley KL, During MJ. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet. 1994 Oct;8(2):148–154. [PubMed]
  • During MJ, Naegele JR, O'Malley KL, Geller AI. Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science. 1994 Nov 25;266(5189):1399–1403. [PMC free article] [PubMed]
  • Latchman DS. Current status review: molecular biology of herpes simplex virus latency. J Exp Pathol (Oxford) 1990 Feb;71(1):133–141. [PubMed]
  • Fink DJ, DeLuca NA, Goins WF, Glorioso JC. Gene transfer to neurons using herpes simplex virus-based vectors. Annu Rev Neurosci. 1996;19:265–287. [PubMed]
  • Dobson AT, Margolis TP, Sedarati F, Stevens JG, Feldman LT. A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons. Neuron. 1990 Sep;5(3):353–360. [PubMed]
  • Howard MK, Kershaw T, Gibb B, Storey N, MacLean AR, Zeng BY, Tel BC, Jenner P, Brown SM, Woolf CJ, et al. High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5. Gene Ther. 1998 Aug;5(8):1137–1147. [PubMed]
  • MacLean AR, ul-Fareed M, Robertson L, Harland J, Brown SM. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence. J Gen Virol. 1991 Mar;72(Pt 3):631–639. [PubMed]
  • Coffin RS, MacLean AR, Latchman DS, Brown SM. Gene delivery to the central and peripheral nervous systems of mice using HSV1 ICP34.5 deletion mutant vectors. Gene Ther. 1996 Oct;3(10):886–891. [PubMed]
  • Wang Q, Guo J, Jia W. Intracerebral recombinant HSV-1 vector does not reactivate latent HSV-1. Gene Ther. 1997 Dec;4(12):1300–1304. [PubMed]
  • Wagstaff MJ, Collaço-Moraes Y, Smith J, de Belleroche JS, Coffin RS, Latchman DS. Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector. J Biol Chem. 1999 Feb 19;274(8):5061–5069. [PubMed]
  • Smith MD, Ensor EA, Coffin RS, Boxer LM, Latchman DS. Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. J Biol Chem. 1998 Jul 3;273(27):16715–16722. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press